国际标准期刊号: 2576-3881

细胞因子生物学杂志

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

抽象的

An Overview of Approved COVID-19 Vaccines and Medication

Esmaeil Farshi

The COVID-19 pandemic has led to a search for effective treatments and vaccines. Several emergency use vaccines have been widely administered, using methods such as introducing virus genetic material, triggering immune response, or using weakened virus forms. Antiviral drugs like remdesivir, anti-inflammatory drugs like dexamethasone, and other medications such as hydroxychloroquine and ivermectin have been used to manage COVID-19 symptoms. Although vaccines show promise in reducing virus spread and severe illness/death, the effectiveness of the medications remains under study and more research is needed. It’s important to only use these medications under medical guidance and to be aware of potential side effects and interactions

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证。